Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- REGALEIndependent statistical analysis of T-Reg Cell Kinetics, Stem Cell Transplant, REGALE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00578539).
- REGARD-PGxIndependent statistical analysis of The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- regARDSIndependent statistical analysis of Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- REGENESIS-LEDIndependent statistical analysis of Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- REGENT-1Independent statistical analysis of Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy: Complete Statistical AnalysisIndependent statistical analysis of Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01470170).
- Regional Anesthesia Following Pediatric Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Regional Anesthesia Following Pediatric Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05688670).
- Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement: Complete Statistical AnalysisIndependent statistical analysis of Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REGKINEIndependent statistical analysis of T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00578461).
- Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02098538).
- Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC: Complete Statistical AnalysisIndependent statistical analysis of Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03099486).
- Regulating Homeostatic Plasticity and the Physiological Response to rTMS: Complete Statistical AnalysisIndependent statistical analysis of Regulating Homeostatic Plasticity and the Physiological Response to rTMS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03309696).
- Regulation of Cervical Mucus Secretion: Complete Statistical AnalysisIndependent statistical analysis of Regulation of Cervical Mucus Secretion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02969590).
- Regulatory Request NIS in Korea: Complete Statistical AnalysisIndependent statistical analysis of Regulatory Request NIS in Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03642717).
- REHAB-HFIndependent statistical analysis of A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REHAB-TAVRIndependent statistical analysis of Home-Based Exercise Program For Recovery After Transcatheter Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02805309).
- Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy: Complete Statistical AnalysisIndependent statistical analysis of Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Rehabilitation in Primary Care: A Project to Maximize the Health Status of Adults With Chronic Illness: Complete Statistical AnalysisIndependent statistical analysis of Rehabilitation in Primary Care: A Project to Maximize the Health Status of Adults With Chronic Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Rehabilitation With or Without Static Progressive Splinting for Wrist Stiffness: Complete Statistical AnalysisIndependent statistical analysis of Rehabilitation With or Without Static Progressive Splinting for Wrist Stiffness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01618227).
- Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment: Complete Statistical AnalysisIndependent statistical analysis of Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00288886).
- Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ReITIrateIndependent statistical analysis of Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies: primary endpoint results, effect estimate with confidence interval,…
- REJOICEIndependent statistical analysis of Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers – a Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT: Complete Statistical AnalysisIndependent statistical analysis of Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RELATIONIndependent statistical analysis of Safety and Efficacy of Ranibizumab in Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01131585).
- Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698): Complete Statistical AnalysisIndependent statistical analysis of Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI): Complete Statistical AnalysisIndependent statistical analysis of Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01681589).
- Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements: Complete Statistical AnalysisIndependent statistical analysis of Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03608826).
- Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Relative Bioavailability of Evobrutinib Tablet Batches: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of Evobrutinib Tablet Batches: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07214922).
- Relative Bioavailability of of Olodaterol and Ketoconazole: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of of Olodaterol and Ketoconazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01153711).
- Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02572609).
- Relative Bioavailability Study of Emodepside IR-tablets and Solution: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Emodepside IR-tablets and Solution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03383523).
- Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size…
- Relative Bioavailability Study of Ropinirole Implants in Parkinson’s Patients on L-Dopa Switched From Oral Ropinirole: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients: Complete Statistical AnalysisIndependent statistical analysis of Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03873987).
- Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions: Complete Statistical AnalysisIndependent statistical analysis of Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RELATIVITY-047Independent statistical analysis of RELATIVITY-047, evaluating relatlimab plus nivolumab versus nivolumab alone in participants with advanced melanoma, including trial design, progression-free survival, statistical methodology, interpretation, and limitations.
- RELAXIndependent statistical analysis of Reducing Lung Cancer-Related Anxiety (RELAX): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02063828).
- RELAX-AHF-2Independent statistical analysis of Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RELAX-AHF-EUComplete statistical analysis of RELAX-AHF-EU, a randomized phase 3 trial evaluating serelaxin plus standard of care versus standard of care in patients with acute heart failure, including time-to-event, categorical, continuous, and longitudinal…
- RELAX-AHF-EUIndependent statistical analysis of Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RELAX-PEDS-PKIndependent statistical analysis of Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size…
- RELAX: A Mobile Application Suite Targeting Obesity and Stress: Complete Statistical AnalysisIndependent statistical analysis of RELAX: A Mobile Application Suite Targeting Obesity and Stress: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02615171).
- RELEASEIndependent statistical analysis of PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- RELEASE MSS5Independent statistical analysis of Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning…